Clinical Trial Update: Effects of Omega 3 in Hemodialysis Patients [NA]

View source ↗

Summary

The clinical trial evaluating omega-3 fatty acids in patients undergoing hemodialysis has completed. The entry indicates completion but does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Laboratoire Régional de Nutrition Humaine | Conditions: Hemodialysis, End Stage Renal Disease | NA | Status: COMPLETED